Rate My Professor Steve Chambers

Chambers' research centers on diagnostics for respiratory infections, infectious diseases treatment, and intermediary metabolism, emphasizing the relationship between bacterial and human metabolism to enable rapid, accurate diagnosis and effective treatment. His innovations include diagnostic breath testing and urine/blood cell-free DNA tests for Legionnaires’ disease. As Chair of the Medical Committee of the Pacific Leprosy Foundation, he advances leprosy elimination in Pacific nations like Kiribati and Samoa through studies on rifamycin-based chemoprophylaxis and intervention modeling. Key publications include “Effect of copper spiked potting mix on the emergence and growth of viola and cabbages” (2026, HortScience), “A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for Leprosy” (2025), “Single-Dose Rifampicin Leprosy Chemoprophylaxis for Household Contacts in Kiribati” (2024), “Adjunctive intravenous then oral vitamin C for moderate and severe community-acquired pneumonia” (2023), and “The inhibitory effect of copper, zinc, and manganese on Legionella longbeachae in potting mix leachate” (2023). In recognition of his contributions, he received the Companion of the New Zealand Order of Merit (CNZM) in 2021. Chambers also served on the Ministry of Health COVID-19 Technical Advisory Group and as a Science Advisor for Te Niwha.